Clinical Trial Update: Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety and efficacy of DuoCAR20.19.22-D95 in adults with relapsed or refractory B-cell malignancies, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• DuoCAR20.19.22-D95

Snippet

Sponsor: University of Kansas Medical Center | Conditions: B-Cell Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING